News & Events

New Partnership Leads To Breakthrough Tumor Profiling Software

28th Jul, 2016

TOMA Biosciences is partnering with Real Time Genomics to develop clinical grade analysis tools to process next-generation sequencing data from all types of tumor samples, including tumor DNA circulating in the blood captured via a “liquid biopsy.” Their goal is to eliminate the inconsistent results that currently plague the field, as evidenced by the recent International Cancer Genome Consortium challenges.



RTG Core 3.7 / RTG Tools 3.7 Released

25th Aug, 2016
Somatic calling / Improved support for targetted sequencing / VCF comparison improvements

Real Time Genomics are pleased to announce the availability of version 3.7 of our full analysis suite, RTG Core, and our...